Velarion Records
Free. Unsubscribe any time.

IONIS PHARMACEUTICALS INC (IONS)

IONIS PHARMACEUTICALS INC filed 86 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 18 reporting owners, covering 156 transactions and 2,351,994 shares. None carries the SEC's AFF10B5ONE flag; all 86 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in IONIS PHARMACEUTICALS INC 156

Adoption dates in IONIS PHARMACEUTICALS INC 24

Results prints in IONIS PHARMACEUTICALS INC 8

Trades before a print in IONIS PHARMACEUTICALS INC 7

Interval to IONIS PHARMACEUTICALS INC’s next reported results date

How the interval and sources are counted →

Adoption dates IONIS PHARMACEUTICALS INC states

Filing text: “10b5-1 Trading Plan adopted by the reporting person on August 13, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.